At a time when cancer remains one of the greatest global health challenges and the development of new treatments has been hampered by lengthy processes with high failure rates, biomedical research has increasingly relied on technologies capable of shortening critical stages. In this context, UFV has formed a partnership with Telefónica and Fundación Vithas to apply quantum computing to the design of drug candidate molecules, with the goal of reducing chemical screening times and guiding the discovery of therapies from early stages.
The Francisco de Vitoria University (UFV), in collaboration with Telefónica and the Vithas Foundation, has launched a project that has applied quantum computing to the design of potential molecules for cancer drugs.
The initiative has focused on accelerating the early stages of drug discovery through a hybrid approach that combines classical and quantum computing, with the aim of reducing the time required for chemical screening compared to traditional methods.
